A Prostate Cancer Study in Men Undergoing Androgen Deprivation Therapy.

Next Previous
Trial Profile

A Prostate Cancer Study in Men Undergoing Androgen Deprivation Therapy.

Completed
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 09 Oct 2009

At a glance

  • Drugs Zoledronic acid (Primary)
  • Indications Male osteoporosis
  • Focus Therapeutic Use
  • Sponsors Novartis; Novartis Pharmaceuticals

    • Most Recent Events

    • 09 Oct 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top